Concepedia

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)

Philip J. Mease, P A Ory, John T. Sharp, Christopher T. Ritchlin, Filip Van den Bosch, Frank R. Wellborne, C. Birbara, G. T. D. Thomson, Renee Perdok, J Medich,

Annals of the Rheumatic Diseases · 2008 · 264 citations · 30 references

DOIFull text

Open access

References

30

Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial

Michael E. Weinblatt, Edward Keystone, Daniel E. Furst et al. · Arthritis & Rheumatism · 2003 · 1.8K citations

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo‐controlled, 52‐week trial

Edward Keystone, Arthur F. Kavanaugh, John T. Sharp et al. · Arthritis & Rheumatism · 2004 · 1.2K citations

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial

Philip J. Mease, Dafna D. Gladman, Christopher T. Ritchlin et al. · Arthritis & Rheumatism · 2005 · 899 citations

Translating the Science of Quality of Life into Practice: What Do Dermatology Life Quality Index Scores Mean?

Yan HongBo, Charles L. Thomas, Michael Harrison et al. · Journal of Investigative Dermatology · 2005 · 815 citations

, , +8

Psoriatic Arthritis (PSA) - An Analysis of 220 Patients

Dafna D. Gladman, Rhonda Shuckett, Michelle Russell et al. · QJM · 1987 · 637 citations

, , +14